Wordt geladen...
Concomitant therapy with pioglitazone and insulin for the treatment of type 2 diabetes
To prevent hyperinsulinemia, which may cause atherosclerosis, thiazolidinediones (TZDs), also known as insulin sensitizers, are often added to the therapeutic regimen of patients with type 2 diabetes who are receiving insulin. The combination of insulin with pioglitazone, a TZD, reduces glycoated he...
Bewaard in:
| Hoofdauteur: | |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Dove Medical Press
2010
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2856574/ https://ncbi.nlm.nih.gov/pubmed/20407626 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|